Sort
21,281 grants matching “influenza”
Adenovirus Vectors for Respiratory Syncytial Virus Vaccination
$300,000Jason Graham Gall · Genvec, Inc. · R43 · FY2008 · AI
Development of CM-IAV1 for Treatment of High-risk Pandemic Influenzas
$300,000Colleen Doyle Cooper · Celdara Medical, Llc · R44 · FY2022 · AI
Development of a Universal Influenza B Vaccine
$300,000Robert Gerald Whalen · Altravax, Inc. · R43 · FY2016 · AI
Treatment of Inflammatory Complications of Viral Pneumonia
$300,000Andy Agrawal · Respana Therapeutics, Inc. · R41 · FY2022 · AI
Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics
$300,000Lijun Rong · Chicago Biosolutions, Inc. · R42 · FY2021 · AI
COMBINATION CHEMOTHERAPY FOR PANDEMIC INFLUENZA
$300,000St. Jude Children'S Research Hospital · R21 · FY2004 · AI
An ultrasensitive virus identification method for acute respiratory virus infections using carbon nanotube arrays-integrated microdevice
$300,000Hongzhang He · Captis Diagnostics · R43 · FY2019 · AI
Enhanced Surveillance for Newly Preventable Diseases (ARI and AGE Surveillance) - Rochester, NY
$300,000Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2019 · IP
Targeting Covid-19 with a Therapeutic Interfering Particle
$300,000Raul Andino · Aleph Therapeutics, Inc. · R41 · FY2021 · AI
Small molecule inhibitors for influenza treatment
$300,000Cyrille Gineste · Alexander Biodiscoveries, Llc · R43 · FY2017 · AI
Rapid, automated, detection of viral and bacterial pathogens causing meningitis
$300,000Andrew Hemmert · Biofire Defense, Llc. · R43 · FY2013 · AI
Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities
$300,000David Turcotte · University Of Massachusetts Lowell · U45 · FY2022 · ES
Sustaining Influenza Surveillance Networks and Response to Seasonal
$300,000Khatuna Zakhashvili · National Center/Disease Ctrl/Med Stats · U51 · FY2012 · IP
Machine learning-based development of serologic test for acute Lyme disease diagnosis
$300,000Laimonas Kelbauskas · Biomorph Technologies Llc · R43 · FY2021 · AI
Strengthening the surveillance and control of Influenza program implemented in Tu
$300,000Afif Ben Salah · Institut Pasteur De Tunis · U51 · FY2015 · IP
Synergistic panfiloviral entry inhibiting antibody drug conjugates
$300,000Zachary David Aron · Microbiotix, Inc · R43 · FY2019 · AI
Alt-and-Renov
$300,000Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2019 · GM
DEVELOPMENT OF DRUGS THAT TARGET THE M2 PROTON CHANNEL FROM INFLUENZA A VIRUS
$300,000Allen Bernard Reitz · Fox Chase Chemical Diversity Center, Inc · R43 · FY2015 · AI
EAGER: Understanding the genomes and strain mutations of SARS-CoV-2 and other viruses using comparative and population genetic approaches
$300,000Jason Ernst · University Of California-Los Angeles · · FY2021 · BIO
PREPARENDNESS AND REPONSE TO AVIAN AND PANDEMIC INFLUENZA
$300,000Davy Chikamata · Ministry Of Health Zambia · U51 · FY2014 · IP
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
$300,000S. Mark Tompkins · University Of Georgia · N01 · FY2021 · AI
Cross-Protective Monoclonal Antibodies for treatment of pandemic Flu
$300,000Christopher H Clegg · Tria Bioscience Corporation · R43 · FY2013 · AI
siRNA Modulation of the Immune Response
$300,000William C Raschke · Virogenics, Inc. · R43 · FY2014 · AI
Development of a vaccine for prevention of Haemophilus influenzae otitis media
$300,000Stephen J. Barenkamp · Saint Louis University · R01 · FY2014 · AI
Improved Vaccines for Influenza B Virus
$300,000Robert Gerald Whalen · Altravax, Inc. · R43 · FY2011 · AI